Published in Cancer J on September 20, 2013
Carcinoid tumors. N Engl J Med (1999) 6.44
Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med (1980) 6.12
Physical activity and the risk of breast cancer. N Engl J Med (1997) 5.85
Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol (2003) 3.56
Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol (2003) 3.07
Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol (1999) 2.97
Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial. J Am Geriatr Soc (2002) 2.80
Review of exercise intervention studies in cancer patients. J Clin Oncol (2005) 2.68
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer (2004) 2.29
Parenteral nutrition in patients receiving cancer chemotherapy. American College of Physicians. Ann Intern Med (1989) 2.18
Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol (2001) 2.05
Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst (1990) 1.92
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.67
Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol (1993) 1.65
Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet (1985) 1.48
Corticosteroid therapy of preterminal gastrointestinal cancer. Cancer (1974) 1.37
Colorectal stenting for malignant and benign disease: outcomes in colorectal stenting. Dis Colon Rectum (2004) 1.37
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol (1991) 1.33
Cancer-related fatigue: can exercise physiology assist oncologists? Lancet Oncol (2003) 1.20
Palliative management of malignant rectosigmoidal obstruction. Colostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res (2004) 1.15
Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol (1999) 1.15
Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev (2000) 1.10
Palliation of gastric outlet obstruction and proximal small bowel obstruction with self-expandable metal stents: a single center series. J Clin Gastroenterol (2005) 1.08
Endoscopic stenting of colonic tumours. Best Pract Res Clin Gastroenterol (2004) 1.08
Megestrol acetate-induced adrenal suppression. J Clin Oncol (1996) 1.06
Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol (1998) 1.05
Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage (2000) 1.04
Understanding and managing cancer cachexia. J Am Coll Surg (2003) 1.03
Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer (2000) 1.00
Maldigestion associated with exocrine pancreatic insufficiency: implications of gastrointestinal physiology and properties of enzyme preparations for a cause-related and patient-tailored treatment. Am J Gastroenterol (1995) 0.95
The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori (1990) 0.94
Analysis of the energy balance in lung cancer patients. Cancer Res (1994) 0.94
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol (1993) 0.93
Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage (1994) 0.93
Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care. Nutrition (1996) 0.92
Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer B Oral Oncol (1994) 0.89
Compartmental body composition of cancer patients by measurement of total body nitrogen, potassium, and water. Metabolism (1981) 0.89
Effects of testosterone replacement and/or resistance exercise on the composition of megestrol acetate stimulated weight gain in elderly men: a randomized controlled trial. J Clin Endocrinol Metab (2002) 0.88
The cannabinoid system: a role in both the homeostatic and hedonic control of eating? Br J Nutr (2003) 0.85
Palliation of malignant rectal obstruction with self-expanding metal stents. Surgery (2005) 0.83
The use of self-expandable metal stents in the palliation of malignant bowel obstruction. Oncol Rep (2004) 0.81
Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer. Chemotherapy (2001) 0.80
The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage (1994) 0.79
Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction. J Pain Symptom Manage (1999) 0.77
Octreotide may prevent definitive intestinal obstruction. J Pain Symptom Manage (1997) 0.76